News

Gluco6 aids in insulin sensitivity enhancement by improving the efficiency of GLUT-4 receptors that facilitate glucose uptake ...
Researchers with City of Hope ®, one of the largest and most advanced cancer research and treatment organizations in the U.S. with its National Medical Center named top 5 in the nation for cancer by U ...
The frequency of high blood glucose among patients receiving PI3K/Akt inhibitors to treat breast cancer has some oncologists ...
Ellen Behrend, VMD, PhD, MS, DACVIM (SAIM), discusses what to monitor in cats on SGLT2 inhibitors, and how it differs from the monitoring required for patients on insulin ...
ZyVersa CEO Stephen Glover said, “ZyVersa is developing Inflammasome ASC Inhibitor IC 100 for treatment of chronic inflammatory diseases, with ...
Background Fibrolamellar carcinoma (FLC), a rare and fatal liver cancer lacking effective drug therapy, is driven by the DNAJ ...
A research team led by Dr. Martin Mollenhauer from the Heart Center at University Hospital Cologne has investigated the link ...
Feline diabetes mellitus (DM) is currently understood to have strong similarities to human type 2 diabetes. Veterinarians ...
Daewoong Pharmaceutical said Friday that it has submitted regulatory applications for its type 2 diabetes medication Envlo ...
Explore medication options for kidney disease and potential side effects. Learn the best treatment options to slow ...
During a a live event, Virginia Kaklamani, MD, DSc, and participants discussed their experiences using a PI3K/AKT inhibitor ...
Tirzepatide is approved for 3 indications in the US: type 2 diabetes, chronic weight management, and obstructive sleep apnea.